Episode Details
Back to Episodes
Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer
Season 1
Episode 156
Published 4 years, 8 months ago
Description
Jonathan Rosenberg describes the results of this positive randomised trial.